Oliver's 1966 experiments demonstrated that removing dermal papilla cells halted hair growth, while reinserting them restored follicle function. This foundational work established these cells as essential regulators of follicle regeneration.
Scientific Mechanisms
Dermal papilla cells function through multiple pathways including:
- Restarting proliferation signalling
- Secreting growth factors (VEGF, FGF, IGF)
- Rebuilding the follicular microenvironment with collagen and laminin
- Providing immune regulation through anti-inflammatory effects
Clinical Evidence
A September 2024 South China Medical University study involving 50 patients with androgenetic alopecia showed improved hair density three months after dermal papilla cell injection, with minimal complications—only temporary redness and swelling.
ReGrowth Biotech's Approach
The company emphasises autologous cell technology, maintains 97%+ cell viability after cryopreservation, and employs pharmaceutical-grade quality controls and third-party genetic verification.
This content is provided for educational purposes and general information. Individual treatment outcomes may vary, and all medical decisions should be made in consultation with qualified healthcare professionals.
